Botanix Pharmaceuticals Ltd
ASX:BOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
AU |
|
C
|
ChipMOS Technologies Inc
F:CPIA
|
TW |
|
B
|
Brixmor Property Group Inc
F:BXR
|
US |
|
St Dupont SA
PAR:DPT
|
FR |
|
Z
|
Zeda Ltd
JSE:ZZD
|
ZA |
|
Peach Property Group AG
F:P6Z
|
CH |
|
Viper Energy Partners LP
NASDAQ:VNOM
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BOT's stock price target?
Not Available
BOT does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Botanix Pharmaceuticals Ltd?
Projected CAGR
196%
The compound annual growth rate for Revenue over the next 3 years is 196%.